Document Detail

Possible hypothyroidism associated with quetiapine.
MedLine Citation:
PMID:  10772436     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To report a case of hypothyroidism occurring after the addition of quetiapine to an existing drug regimen. CASE SUMMARY: A 46-year-old African-American woman diagnosed with schizoaffective disorder, bipolar type, and a four-year history of successfully treated hyperthyroidism, was suboptimally responsive to olanzapine treatment. Transition from olanzapine to quetiapine was initiated and, approximately two months after adding quetiapine to a standing pharmacotherapeutic regimen, the patient developed an elevated thyroid-stimulating hormone (TSH) concentration of 8.45 microU/L. A diagnosis of hypothyroidism was subsequently made, treatment with levothyroxine was initiated, and the patient's thyroid function became stable. DISCUSSION: Drug induced hypothyroidism is known to occur with several medications. Quetiapine is an atypical antipsychotic with the potential to decrease thyroid hormone concentrations in some patients; this effect may be dose related. Despite this known adverse effect, the manufacturer of quetiapine reports that elevated TSH concentrations and subsequent treatment with thyroid hormone supplementation have occurred only rarely. We report the development of hypothyroidism in a patient who had previously received successful radioactive iodine treatment for hyperthyroidism in 1994, but who had no detected thyroid abnormalities until treatment with quetiapine was started four years later. CONCLUSIONS: Patients with compromised thyroid function who receive treatment with quetiapine may develop hypothyroidism. Appropriate care for these patients may include an increased awareness of possible hypothyroidism and consideration of thyroid function monitoring.
B M Feret; C F Caley
Related Documents :
6307436 - Relationship of cyclic amp binding capacity and estrogen receptor to hormone sensitivit...
13523396 - Hyperthyroidism; diagnosis by failure of triiodothyronine to suppress uptake of iodine ...
6421866 - Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long t...
7488816 - Frequency, clinical and laboratory features of thyroiditis in girls with turner's syndr...
8358126 - A patient with congenital plasminogen deficiency manifesting primary pulmonary hyperten...
19910286 - Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Annals of pharmacotherapy     Volume:  34     ISSN:  1060-0280     ISO Abbreviation:  Ann Pharmacother     Publication Date:  2000 Apr 
Date Detail:
Created Date:  2000-06-23     Completed Date:  2000-06-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9203131     Medline TA:  Ann Pharmacother     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  483-6     Citation Subset:  IM    
Department of Pharmacy, Hartford Hospital, CT, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antipsychotic Agents / adverse effects*
Dibenzothiazepines / adverse effects*
Hypothyroidism / chemically induced*
Middle Aged
Thyroid Function Tests
Reg. No./Substance:
0/Antipsychotic Agents; 0/Dibenzothiazepines; 0/quetiapine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Epididymo-orchitis following intravesical bacillus Calmette-Guérin therapy.
Next Document:  Combination therapy with interferon and ribavirin in the treatment of chronic hepatitis C infection.